TL;DR: When Canada and Germany normalized cannabis, the biggest farms didn’t win. The most certified ones did. With Schedule III now in effect for California medical operators, the same dynamic is taking shape here. Your DCC license is permission to grow. DEA registration and GMP certification are permission to ship. The farms that start that process now will be positioned when the interstate door opens. The ones that wait will spend two years catching up.
When Canada legalized cannabis in 2018, everyone assumed the biggest farms would dominate. They had the land, the capital, and the output.
What actually happened was different. The operators who captured the highest-value markets (medical exports, EU contracts, pharmaceutical partnerships) weren’t the largest producers. They were the most certified ones.
Germany told the same story from the other side. When Germany opened its medical cannabis market, it didn’t go looking for the cheapest flower. They went looking for an EU-GMP certified supply with a documented chain of custody from seed to shelf. Canadian operators who had invested in those certifications years before they needed them walked into contracts worth tens of millions. Operators who hadn’t been locked out entirely. Not because their cannabis was inferior, but because they couldn’t prove it wasn’t.
That distinction is coming to California.
What Schedule III Actually Unlocks
The April 23 DEA order moving state-licensed medical cannabis to Schedule III didn’t just change the tax code. It opened a door that has been closed since California first issued commercial licenses. For the first time, a federally compliant pathway to interstate and eventually international cannabis commerce is visible on the horizon.
But visible isn’t the same as open. And when it opens, it won’t open equally for everyone.
California’s SB 1326 already authorizes interstate cannabis commerce, the moment federal law allows it. The DEA registration window is open now for qualifying medical operators. GMP certification programs exist and are achievable today.
The operators who will be first through that door are the ones already standing in line.
The Chain of Custody Lesson
Canada’s failures were instructive. Several of the largest Licensed Producers collapsed not from lack of demand, but from compliance failures: documentation gaps that triggered enforcement. In a federally regulated environment, a single recall can erode years of brand equity.
Germany’s buyers (hospitals, pharmacies, insurance-covered dispensaries) required documentation that most operators weren’t prepared to provide. Batch records. COAs tied to specific lots. Temperature-controlled chain of custody from harvest through import. The cannabis itself was almost secondary. The paper trail was the product.
California growers have been operating under DCC track-and-trace since licensure. That’s actually a head start. Metrc records, if maintained cleanly, are the beginning of a GMP-compliant documentation system. The infrastructure is closer than most California cannabis operators realize.
What GMP Actually Means for a California Cultivator
GMP (Good Manufacturing Practice) is not a single certification. It’s a framework. For California cannabis operators, the three relevant standards are:
- EU-GMP: Required for European markets. The gold standard globally.
- NSF/ANSI 455: The emerging U.S. standard for cannabis manufacturing.
- DEA manufacturing registration: Required for Schedule III interstate commerce.
None of these is quick. EU-GMP audits take a minimum of 12 to 18 months of preparation. For most California cultivators, the DEA registration assessment is the logical first step. It is the most immediate; it is tied directly to the April 23 order, and it maps to the interstate commerce pathway that SB 1326 anticipates.
The farms that start now will be positioned when the door opens. The farms that wait will spend two years catching up while their competitors are already shipping.
Your California Cannabis License Is Your Permission to Grow
The DCC license you hold will never be enough for what’s coming. In a normalized federal market, a California cultivation license is table stakes: the minimum required to participate at the state level.
DEA registration is what makes you a federally recognized handler of a Schedule III controlled substance.
GMP certification is what makes you a credible supplier to any buyer operating under federal or international pharmaceutical standards.
Without both, you are a state-licensed grower in a world that is rapidly building federal infrastructure around you.
What to Do Before the Door Opens
Three things worth doing now, regardless of where federal normalization ultimately lands:
Get a DEA registration assessment. Understand what registration requirements apply to your license type and whether you qualify under the April 23 order. This is the most immediate step and the most directly tied to Schedule III benefits.
Conduct a chain-of-custody audit of your Metrc records. If you had to produce batch documentation for an outside buyer tomorrow (lot numbers, COAs, harvest records, input logs), could you? If the answer is anything other than yes, that’s the gap to close.
Get educated on GMP standards before you need them. EU-GMP and NSF/ANSI 455 are publicly available frameworks. Understanding what an audit looks for costs nothing. Being surprised by it costs everything.
The Bottom Line
Canada had more cannabis than the world needed. Germany had more demand than Canada could properly serve. The operators who bridged that gap weren’t the biggest. They were the most compliant, the most documented, and the most certified.
California has the same opportunity and the same risk. The license gets you in the game. The certification gets you the contracts.
Disclaimer: I am a cannabis compliance consultant, not an attorney or CPA. This article is for educational purposes only and does not constitute legal or tax advice. Consult qualified legal and tax professionals before making operational or licensing decisions.